 |
|
Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study
Kyubok Jin, Tae Hyun Ban, Ji Yong Jung, Ae Jin Kim, Yaerim Kim, So-Young Lee, Dong Ho Yang, Bum Soon Choi, Kook-Hwan Oh, Jieun Kim, Young Joo Kwon, Jong Wook Choi, Gheun-Ho Kim
Kidney Res Clin Pract. 2018;37(2):157-166. Published online 2018 Jun 30 DOI: https://doi.org/10.23876/j.krcp.2018.37.2.157
|
|
Citations to this article as recorded by
 Characterization of Medication Trends for Chronic Kidney Disease: Mineral and Bone Disorder Treatment Using Electronic Health Record-Based Common Data Model
Sungdam Han, Minkook Son, Byungjin Choi, ChulHyoung Park, Dong Ho Shin, Jong Hwan Jung, Min-Jeong Lee, Gyu-Tae Shin, Heungsoo Kim, Rae Woong Park, Inwhee Park, Mateusz Maciejczyk
BioMed Research International.2021; 2021: 1. CrossRef The combined prognostic significance of alkaline phosphatase and vascular calcification in patients with end-stage kidney disease
Da Won Kim, So Yeon Hwang, Yun Jung Nam, Dongryul Kim, Seok Joon Shin, Hye Eun Yoon
Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(9): 1476. CrossRef Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease
Yun Jung Oh, Hyunsook Kim, Ae Jin Kim, Han Ro, Jae Hyun Chang, Hyun Hee Lee, Wookyung Chung, Hee-Sook Jun, Ji Yong Jung
International Journal of Molecular Sciences.2020; 21(10): 3539. CrossRef Why do we need regional chronic kidney disease-mineral bone disorders guidelines?
Hyung Jung Oh, Dong-Ryeol Ryu
Kidney Research and Clinical Practice.2018; 37(2): 101. CrossRef
|